Academics · Demo University

Analytics Database

Search filters

Field Political Science

Chemistry English Political Science

University any

All

Brown Columbia Cornell Dartmouth Harvard Penn Princeton Yale

Years all years

5y 10y All

Publication type 3 of 8

All

articles books edited volumes chapters conference papers reports reviews other works

Academic rank any

All

Works CV or Scholar

CV Scholar

Journal tier any

All

A* A B unranked

How a figure is made

Citation weight off, every journal counts 1. Change it

Department formula mean * log(1 + people). Change it

Back to the list

Academic

Daniel Paul Carpenter

Academic

RankDistinguished

As of2025 · CV

DepartmentHarvard Government

UniversityHarvard

FieldPolitical Science

Scholarprofile

Totals

Publications142

Citations13,814

h-index44 · Scholar

Citations per year in post394.7

Years in post35 from the CV positions

Coverage

Works with a count96 of 142

Share68%

Positions

Chair, Department of Government2022–2025

Director, Social Sciences Program, Radcliffe…2021–2022

Professeur invité, Université de Paris-Dauphi…2015

Professeur invité, L’École des Hautes Études…2014

Director, Social Sciences Program, Radcliffe…2013–2020

Chercheur Visitant/Professeur Invité, L’Insti…2011–2013

Allie S. Freed Professor of Government, Harva…2007–

Director, Center for American Political Studi…2006–2015

and 13 more

Top venues 47 venues

The 8 holding the most of these works; 39 more hold at least one.

Perspectives on Politics9

Health Affairs8

Journal of Health Politics Policy and Law7

Studies in American Political Development6

New England Journal of Medicine5

American Journal of Political Science4

American Political Science Review4

Social Science History4

Publications per year

Works this academic published in each year, by the year each work appeared; an undated work is in no year, and a work two colleagues wrote counts for each of them. The kind, works and year filters decide which works are here at all.

Citations per year

Citations received in each year, from this academic’s verified Scholar profile, which counts every citation to everything they ever wrote: no publication filter reaches this line - not the kinds, not the works switch, not the year window on publication - and no journal weight either. It is a profile total, so it does not match the works listed below.

Publications 142 works

Every work these filters select, most cited first and the works with no count at the end: a work nobody has a figure for is unknown, never a zero to be ranked among the works that have one, and it prints an em dash. Each figure is that work’s own citations - Scholar’s count where there is one, else OpenAlex’s - and is not weighted.

Year	Title	Venue	Kind	Citations
2001	The Forging of Bureaucratic Autonomy: Networks, Reputations and Policy Innovation in Executive Agencies, 1862-1928	—	book	3,160
2010	Reputation and Power: Organizational Image and Pharmaceutical Regulation at the FDA	—	book	1,970
2012	Reputation and Public Administration	Public Administration Review	article	999
2015	Global health security: the wider lessons from the west African Ebola virus disease epidemic	The Lancet	article	748
2016	Failure of Investigational Drugs in Late-Stage Clinical Development and Publication of Trial Results	JAMA Internal Medicine	article	594
2008	A Formal Model of Learning and Policy Diffusion: A Comment on Multiple Unknown Policies.	American Political Science Review	article	530
2003	The impact of a celebrity promotional campaign on the use of colon cancer screening: the Katie Couric effect	—	article	510
2002	Groups, the Media, Agency Waiting Costs, and FDA Drug Approval	American Journal of Political Science	article	464
2004	Protection without Capture: Product Approval by a Politically Responsive, Learning Regulator	American Political Science Review	article	326
1996	Adaptive Signal Processing, Hierarchy, and Budgetary Control in Federal Regulation	American Political Science Review	article	312
2004	Friends, Brokers and Transitivity: Who Talks with Whom in Washington Lobbying?	The Journal of Politics	article	294
2008	Drug Review Deadlines and Subsequent Safety Problems	New England Journal of Medicine	article	250
2015	Transactional Authority and Bureaucratic Politics	Journal of Public Administration Research and Theory	article	223
2004	The Political Economy of FDA Drug Approval: Processing, Politics and Implications for Policy	Health Affairs	article	192
1998	The Strength of Weak Ties in Lobbying: Evidence from Health Care Politics in the United States	Journal of Theoretical Politics	article	175
2012	Is Health Politics Different?	Annual Review of Political Science	article	169
2003	Information and Contact-Making in Policy Networks: A Model with Evidence from the U.S. Health Policy Domain	Rationality and Society	article	166
2004	Political Learning from Rare Events: Poisson Inference, Fiscal Constraints, and the Lifetime of Bureaus	Political Analysis	article	156
2012	The Complications of Controlling Bureaucratic Timing: FDA Review Deadlines and Postmarket Drug Safety	American Journal of Political Science	article	147
2014	When Canvassers Became Activists: Antislavery Petitioning and the Political Mobilization of American Women	American Political Science Review	article	142
2003	Executive Power in American Institutional Development	Perspectives on Politics	article	135
2010	Institutional Strangulation: Bureaucratic Politics and Financial Reform in the Obama Administration	Perspectives on Politics	article	131
2021	Democracy by Petition: Popular Politics in Transformation, 1790-1870	—	book	107
2007	Regulatory Errors with Endogenous Agendas	American Journal of Political Science	article	104
2000	State Building through Reputation Building: Policy Innovation and Coalitions of Esteem at the Post Office, 1883-1912	Studies in American Political Development	article	98
2011	Reputation and Precedent in the Bevacizumab Decision	New England Journal of Medicine	article	92
2006	Whose deaths matter? Mortality, advocacy, and attention to disease in the mass media	Journal of Health Politics Policy and Law	article	92
2019	U.S. Nationwide Disclosure of Industry Payments and Public Trust in Physicians	JAMA Network Open	article	78
2016	Recruitment by Petition: American Abolitionism, French Protestantism, English Suppression	Perspectives on Politics	article	76
2001	The Political Foundations of Bureaucratic Autonomy: A Reply to Kernell	Studies in American Political Development	article	75
2017	Public Awareness of and Contact with Physicians Who Receive Industry Payments: A Survey	Journal of General Internal Medicine	article	74
2007	Policy Tragedy and the Emergence of Regulation: The Food, Drug and Cosmetic Act of 1938	Studies in American Political Development	article	72
2010	U.S. Pharmaceutical Innovation in an International Context	American Journal of Public Health	article	69
2003	Approval Times for New Drugs: Does the Source of Funding for FDA Staff Matter?	Health Affairs	article	67
2011	Bioequivalence: The Regulatory Career of a Pharmaceutical Concept	—	article	63
2000	Commentary: What is the marginal value of analytic narratives?	Social Science History	article	49
2010	Early Entrant Protection in Approval Regulation: Theory and Evidence from FDA Drug Review	The Journal of Law Economics and Organization	article	45
2021	Congressional Representation by Petition: Assessing the Voices of the Voteless in a Comprehensive New Database, 1789-1949	Legislative Studies Quarterly	article	44
2023	Agenda Democracy	Annual Review of Political Science	article	41
2019	Effect of the Public Disclosure of Industry Payments Information on Patients: Results from a Population-Based Natural Experiment	BMJ Open	article	41
2010	Approval Regulation and Endogenous Consumer Confidence: Theory and Analogies to Licensing, Safety and Financial Regulation	—	article	41
2020	On Categories and the Countability of Things Bureaucratic: Turning from Wilson (back) to Interpretation	—	article	40
2015	Party Formation Through Petitions: The Whigs and the Bank War of 1832-34	Studies in American Political Development	article	37
2018	Suffrage Petitioning as Formative Practice: American Women Presage and Prepare for the Vote, 1870-1920	Studies in American Political Development	article	36
2020	Data and Methods for Analyzing Special Interest Influence in Rulemaking	Interest Groups & Advocacy	article	30
2019	L’éruption patriote: The Revolt against Dalhousie and the Petitioning Explosion in Nineteenth-Century French Canada	Social Science History	article	30
2014	A Systematic Review of State and Manufacturer Physician Payment Disclosure Websites: Implications for Implementation of the Sunshine Act	—	article	26
2017	Tobacco industry response and outcomes of a ban on lights descriptors on cigarette packaging	—	article	23
2005	The Political Logic of Regulatory Error: Some Theoretical Reflections on the Vioxx Episode	Nature Reviews Drug Discovery	article	23
2004	Accelerating Approval Times for New Drugs in the U.S.	—	article	22
2014	Quantifying The Food and Drug Administration’s Rulemaking Delays Highlights The Need For Transparency	Health Affairs	article	21
2024	Trust in the Food and Drug Administration: A National Survey Study	—	article	20
2018	Paths of Recruitment: Rational Social Prospecting in Petition Canvassing	American Journal of Political Science	article	19
2011	A Unique Physician Identifier for the Physician Payments Sunshine Act	JAMA	article	19
2024	Lawyers as Lobbyists: Regulatory Advocacy in American Finance	Perspectives on Politics	article	18
2014	Assessment of US pathway for approving medical devices for rare conditions	—	article	18
2023	The Revolving Door In Health Care Regulation: Study examines revolving door trends of people who move from private industry to the Department of Health and Hum…	Health Affairs	article	17
2006	Reputation, Gatekeeping and the Politics of Post-marketing Drug Regulation	—	article	17
2003	The Multiple and Material Legacies of Stephen Skowronek	Social Science History	article	17
2017	FDA Transparency in an Inescapably Political World	—	article	16
2013	Time Series Analyses of the Effect of FDA Communications on Use of Prescription Weight Loss Medications	—	article	16
2014	Target small firms for antibiotic innovation	Science	article	15
2012	Warnings without Guidance: Patient responses to an FDA warning about Ezetimibe	Medical Care	article	15
1998	Centralization and the Corporate Metaphor in Executive Departments, 1880-1928	Studies in American Political Development	article	15
2023	Securing the Trustworthiness of the FDA to Build Public Trust in Vaccines	The Hastings Center Report	article	14
2015	Accelerating innovation for rapid diagnostics and targeted antibacterials	Nature Biotechnology	article	12
2012	Strengthen and Stabilize the FDA	Nature	article	12
2015	Paying for Innovation: Reimbursement Incentives for Novel Antibiotics	Science Translational Medicine	article	11
2016	Internal Governance of Agencies: The Sieve, the Shove, the Show	—	article	10
2014	Can Expedited FDA Drug Approval without Expedited Follow-Up Be Trusted?	JAMA Internal Medicine	article	10
2008	Drug-review deadlines and safety problems-Reply	New England Journal of Medicine	article	9
2017	Statutory Clarity and Regulatory Precedent on Substantial Equivalence Standards in Tobacco Governance: Implications for Understanding Sections 905 and 910 of t…	Journal of Health Politics Policy and Law	article	8
2022	The Popular Origins of Legislative Jurisdictions: Petitions and Standing Committee Formation in Colonial Virginia and the Early U.S. House	The Journal of Politics	article	7
2014	Biology as an agent of chemical and mineralogical change in soil	—	article	7
2013	Preventing Regulatory Capture: Special Interest Influence in Regulation and How To Limit It	—	edited volume	7
2004	Commentary: Staff Resources Speed FDA Drug Review: A Critical Analysis of the Returns to Resources in Approval Regulation	Journal of Health Politics Policy and Law	article	7
2002	The impact of a celebrity spokesperson on preventive health behavior: The Katie Couric effect.	Journal of General Internal Medicine	article	7
2020	Quand le pétitionnement contribue au façonnage de l’Agenda Politique : L’Abolition de la Tenure Seigneuriale au Canada Français, 1849-1854	Participations	article	6
2016	Sovereignty and Survivance – The Pathways of Native Politics	Perspectives on Politics	article	6
2004	Gatekeeping and the FDA’s Role in Human Subjects Protection	—	article	6
2025	Does Policy Uncertainty Boost Vaccine Hesitancy? Political Controversy, the FDA and COVID-19 Vaccine Hesitancy in Fall 2020	Journal of Health Politics Policy and Law	article	5
2025	Flaws in the FDA’s new priority voucher program	New England Journal of Medicine	article	5
2019	La réputation organisationnelle de l’État fédéral dans un contexte général de malaise politique	—	article	4
2017	Scott Gottlieb and the Credibility of U.S. Therapeutics	New England Journal of Medicine	article	4
2014	Strengths and Weaknesses in the Case for SEC Capture	—	article	4
1999	From Patronage to Policy: The Centralization Campaign in Iowa Post Offices, 1880-1910	—	article	4
2019	The social transformation of American medicine: The rise of a sovereign profession and the making of a vast industry	Journal of Health Politics Policy and Law	article	3
2014	Accounting for Financial Innovation and Borrower Confidence in Financial Rulemaking: Analogies from Health Policy	The Journal of Legal Studies	article	3
2026	Authoritarian State Conversion: America's Past and the Trumpian Future	Political Science Quarterly	article	2
2025	Petitioning as Governance: The Scattered and Multinational World of the Early United States	Journal of the Early Republic	article	2
2011	Information Disclosure and the Physician Payments Sunshine Act—Reply	JAMA	article	2
2005	A Modest Proposal for Financing Postmarketing Drug Safety Studies by Augmenting FDA User Fees	Health Affairs	article	2
2023	Just How Much of History is Countable?	Political Science Quarterly	article	1
2016	Bridging the Information Gap: Legislative Member Organizations as Social Networks in the United States and the European Union	Perspectives on Politics	article	1
2013	Keeping Tabs on Financial Innovation: Product Identifiers in Consumer Financial Regulation	—	article	1
2010	How Dangerous is the FDA?: An Exchange	The New York Review of Books	article	1
2026	Heuristic Agenda Closure in Administrative Government	The Forum	article	—
2024	Vaccine messaging by the FDA: A randomized national survey study	Journal of General Internal Medicine	article	—
2023	Strategic Realism, not Optimism: Bayesian and Indigenous Perspectives on the Democratizing Petition	Social Science History	article	—
2023	What Should Be Clinicians’ Roles in Regulatory Assessment of Prospective Interventions’ Risks of Exacerbating Inequity?	—	article	—
2023	AMA Journal of Ethics®	—	article	—
2022	The Popular Origins of Legislative Jurisdictions: Petitions and Standing Committee Formation in Colonial Virginia and the Early US House	—	book	—
2021	Why COVID Vaccines for Kids Are Taking So Long	The New York Times	article	—
2021	The Menthol Cigarette Ban Shows There’s No Democracy Without Petitions	Boston Review	article	—
2020	Here’s what Pelosi could do if Republicans tried to manipulate the presidential election’s outcome	The Monkey Cage	article	—
2020	There’s only one way out of the COVID-19 Crisis. It’s time for a new New Deal	Slate	article	—
2020	Political war-gaming for the republic	The Boston Globe	article	—
2020	When petitions shape the political agenda: The abolition of seigneurial tenure in French Canada (1849–1854)	Participations	article	—
2020	American Democracy is in the Mail	Boston Review	article	—
2019	Dear Reader, As we reach the final issue of Pharmaceutical Medicine for 2019, we wish to reflect on another successful year’s achieve-ments, and to thank all t…	—	article	—
2019	Organizational reputation of the US Federal State in a context of political unease	—	article	—
2018	Lobbying the Rulemakers with Lawyers: Reflections from the Volcker Rule	—	article	—
2017	Yes, signing those petitions makes a difference – even if they don’t change Trump’s mind	The Monkey Cage	article	—
2016	Lawmakers must ask tough questions about the 21st Century Cures Act	The Hill	article	—
2015	What Piketty Missed: The Banks	Washington Monthly	article	—
2015	Principe de précaution et innovation médicamenteuse	—	article	—
2015	Substandard and falsified drugs: A threat to human and global security	The Lancet	article	—
2015	The ethics of publishing human germline research	—	article	—
2014	How ordinary petitions helped end slavery and make women into political activists	The Monkey Cage	article	—
2012	Response to John Ferejohn's review of Reputation and Power: Organizational Image and Pharmaceutical Regulation at the FDA	Perspectives on Politics	article	—
2012	Emma Sherlock, Angela Lidgett, Kerry Leigh & Paul Eggleton	—	article	—
2011	Deadline Washington / Why Washington Always Works Down to the Wire	The Washington Post	article	—
2011	Capitalism, Counterfactuals, and the National State: Reflections on Richard White's Railroaded.	—	article	—
2011	Institute on California and the West Railroaded Workshop, Huntington Library, San Marino, CA, July 9, 2011: capitalism, counterfactuals, and the national state…	—	article	—
2011	Free the F.D.A.	The New York Times	article	—
2010	Why Consumers Can’t Trust the Fed	The New York Times	article	—
2010	A Review of:“Madison's Managers: Public Administration and the Constitution by Anthony M. Bertelli and Laurence E. Lynn, Jr.” Madison's Managers: Public Admini…	—	article	—
2009	How to Restore Consumer Confidence	The Boston Globe	article	—
2008	Drug-review deadlines linked to safety problems	—	article	—
2007	Some Thoughts on the Relationship between Model and Narrative	—	article	—
2007	The Leaning Tower of PISA: Fundamental Problems in Ignorance-Based Theories of State Autonomy	Critical Review	article	—
2007	The leaning tower of “pisa”: Public ignorance, issue publics, and state autonomy: Reply to DeCanio	Critical Review	article	—
2006	Whose Deaths Matter? Mortality, Identity, and Attention to Disease in the Mass Media	Journal of Health Politics Policy and Law	article	—
2005	Using cost-effectiveness analysis to improve health care: Opportunities and barriers	Health Affairs	article	—
2004	Staff Resources Speed FDA Drug Review	Journal of Health Politics Policy and Law	article	—
2004	Drug Safety: The Author Responds	Health Affairs	article	—
2003	The Impact of a Celebrity Promotional Campaign on the Use of Colon Cancer Screening: The Case of Katie Couric	—	article	—
2003	Delegating Powers: A Transaction-Cost Approach to Policymaking under Separate Powers. By David Epstein and Sharyn O’Halloran. Cambridge: Cambridge University P…	Perspectives on Politics	article	—
2003	Protecting America's Health: The FDA, Business, And One Hundred Years Of Regulation Philip J. Hilts	—	article	—
2003	DECEMBER 2003-PERSPECTIVE: Defending Submission-Year Analyses Of New Drug Approvals	Health Affairs	article	—
2003	David Epstein and Sharyn O'Halloran, Delegating Powers: A Transaction-Cost Approach to Policymaking under Separate Powers	Perspectives on Politics	article	—
2001	Anvil or Wellspring? The Use of Narrative in Congressional Studies	—	article	—